To study the role of tofacitinib and betamethasone pulse in the treatment of vitiligo at a tertiary care centre: an observational comparative study
Background: According to recent updates, both genetic and non-genetic factors play a role in the pathogenesis of vitiligo, and CD8T lymphocytes and interferon γ are also known to result in vitiligo. The new oral biologic tofacitinib, which is a Janus kinase inhibitor, is a new addition to the armame...
Saved in:
Main Authors: | Rashmi Singh, Surabhi Shandilya, Kamalpreet Kaur Bhaikhel, Gopi Krishna Maddali |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2024-01-01
|
Series: | Pigment International |
Subjects: | |
Online Access: | https://journals.lww.com/10.4103/pigmentinternational.pigmentinternational_38_22 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Development and Evaluation of in situ eye gel for delivery of gatifloxacin and betamethasone sodium phosphate
by: Fatima Mustafa Ali, et al.
Published: (2025-01-01) -
Advances in the etiopathogenesis of vitiligo
by: Thomas Mathew, et al.
Published: (2024-12-01) -
Improvement of Fatigue in Patients with Ankylosing Spondylitis Receiving Tofacitinib: Analyses of a Phase 3 Randomized Controlled Trial
by: Laure Gossec, et al.
Published: (2024-12-01) -
Relationships of dermatologic symptoms and quality of life in patients with psoriatic arthritis: analysis of two tofacitinib phase III studies
by: Peter C. Taylor, et al.
Published: (2022-07-01) -
Phototherapy in vitiligo
by: Anuradha Bishnoi, et al.
Published: (2024-12-01)